Hodges Capital Management Inc. Halozyme Therapeutics, Inc. Transaction History
Hodges Capital Management Inc.
- $1.44 Billion
- Q1 2025
A detailed history of Hodges Capital Management Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Hodges Capital Management Inc. holds 371,640 shares of HALO stock, worth $20.2 Million. This represents 1.64% of its overall portfolio holdings.
Number of Shares
371,640
Previous 332,954
11.62%
Holding current value
$20.2 Million
Previous $15.9 Million
48.98%
% of portfolio
1.64%
Previous 1.02%
Shares
6 transactions
Others Institutions Holding HALO
# of Institutions
595Shares Held
124MCall Options Held
320KPut Options Held
113K-
Black Rock Inc. New York, NY17.6MShares$959 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$698 Million0.02% of portfolio
-
State Street Corp Boston, MA6.05MShares$329 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA3.89MShares$212 Million0.05% of portfolio
-
Snyder Capital Management L P San Francisco, CA3.67MShares$200 Million5.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.58B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...